SCHEMBL932469

SCHEMBL932469

CC1=NC(c2cccc(Br)c2)(c2cc(C)c(OC(F)F)c(C)c2)NC1=S

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.31
APP P05067 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL947083 0.86 BACE1 (0.36) BACE1
SCHEMBL944396 0.79 NCOA1 (0.33)
SCHEMBL6920536 0.79 BACE1 (0.39) BACE1
SCHEMBL944383 0.77
SCHEMBL932175 0.73 BACE1 (0.51) BACE1APP
SCHEMBL945865 0.72 ALDH1A1 (0.35) BACE1
SCHEMBL946379 0.69
SCHEMBL943316 0.69 ALDH1A1 (0.34) BACE1
SCHEMBL3359122 0.68 BACE1 (0.36) BACE1APP
SCHEMBL3359125 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002407-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed